Shilpa Medicare Unit VI gets GMP approval from EMA Ruchika Sharma7 May 2025 10:30 AM ISTKarnataka: Shilpa Medicare has announced that the company's Unit VI, Dabaspet, Bengaluru, Karnataka, India has received GMP approval from...
Shilpa Biologics Dharwad site gets European GMP certification Ruchika Sharma5 May 2025 1:30 PM ISTShilpa Medicare has announced that its Biologics arm, Shilpa Biologics site at Dharwad, Karnataka, has received its European GMP certification for...
Shilpa Medicare bags USFDA approval for Varenicline Tablets for smoking cessation Ruchika Sharma10 April 2025 1:17 PM ISTKarnataka: Shilpa Medicare Limited has received approval from the US Food and Drugs Administration (USFDA) for Varenicline Tablets, 0.5 and 1...
Shilpa Medicare marketing partner Amneal Pharma unveils multiple myeloma treatment Boruzu Ruchika Sharma4 April 2025 12:30 PM ISTKarnataka: Shilpa Medicare has announced that the Company's marketing partner, Amneal Pharmaceuticals, has launched BORUZU, (Bortezomib...
Shilpa Biologicals, mAbTree Biologics ink pact for cancer drug Ruchika Sharma18 March 2025 12:30 PM ISTKarnataka: Shilpa Biologicals Pvt Ltd., a fully owned subsidiary of Shilpa Medicare Limited has signed an exclusive partnership...
USFDA concludes inspection at Shilpa Medicare Raichur unit Ruchika Sharma15 March 2025 3:50 PM ISTKarnataka: Shilpa Medicare has announced that the United States Food and Drug Administration (USFDA) has conducted an inspection at...
Shilpa Medicare arm gets 1 UFSDA observation for Raichur Unit Ruchika Sharma8 March 2025 12:29 PM ISTKarnataka: Shilpa Medicare has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection with one observation...
Shilpa Medicare Gets CDSCO Panel Nod for Novel NAFLD Drug, Advances to Marketing Approval Stage Farhat Nasim14 Feb 2025 2:04 PM ISTRaichur: Shilpa Medicare Limited, recently announced that its Investigational New Drug (IND), Nor-Ursodeoxycholic Acid Tablets (500 mg), has received...
Shilpa Pharma Lifesciences receives CEP from EDQM for API, Teriflunomide Ruchika Sharma24 Jan 2025 12:30 PM ISTKarnataka: Shilpa Pharma Lifesciences Limited, a 100 percent subsidiary of Shilpa Medicare Limited has received certificate of suitability (CEP)...
Shilpa Medicare receives European marketing authorization for Tadalafil Orodispersible Films for erectile dysfunction Ruchika Sharma11 Jan 2025 2:06 PM ISTShilpa Medicare has informed in a BSE filing that the Company has received marketing authorization from Portugal, Europe, for Tadalafil...
Shilpa Medicare receives Eurasia GMP approval for 2 Telangana units Ruchika Sharma28 Dec 2024 11:30 AM ISTKarnataka: In a BSE filing, Shilpa Medicare informed that its Unit IV and Unit VII in Telangana have received Good Manufacturing Practice...
Shilpa Medicare receives Europe GMP Certification for Hyderabad facility Ruchika Sharma22 Dec 2024 3:31 PM ISTKarnataka: Shilpa Medicare has received the Good Manufacturing Practice (GMP) Certification after the successful closure of the EMA,...
